Respiratory fungal infections: molecular diagnostic tests

Kevin C Hazen1

  • 1Clinical Microbiology Laboratory, Department of Pathology, Duke University Health System, 2902 DUMC, 116 CARL Building, Durham, NC 27710, USA.

Insights

Fungal respiratory infections, like pneumonia, can affect anyone. New molecular assays offer a sensitive tool to help doctors diagnose fungal infections in patients.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Diagnostic Microbiology

Background:

  • Fungal respiratory infections, primarily pneumonia, are a significant clinical concern.
  • While immunocompetent individuals can develop fungal infections, the range of causative agents is limited.
  • Accurate diagnosis is crucial for effective treatment of fungal pneumonia.

Purpose of the Study:

  • To highlight the diagnostic challenges in identifying fungal respiratory infections.
  • To introduce molecular assays as a novel diagnostic approach.
  • To assess the potential of molecular assays in determining the likelihood of fungal causation.

Main Methods:

  • Review of current diagnostic methods for fungal respiratory infections.
  • Discussion of the principles and sensitivity of molecular assay technologies.
  • Evaluation of how molecular data can classify fungal infection probability (definitive, probable, possible).

Main Results:

  • Fungal pneumonia is a common manifestation of respiratory fungal infections.
  • Molecular assays demonstrate high sensitivity for fungal detection.
  • These assays can aid in classifying the certainty of fungal involvement in patient cases.

Conclusions:

  • Molecular assays represent a valuable addition to the diagnostic armamentarium for fungal respiratory infections.
  • Improved diagnostic accuracy can lead to more timely and appropriate patient management.
  • Further integration of molecular diagnostics is recommended for clinical practice.